Stay updated on Sitravatinib Combo vs Docetaxel in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib Combo vs Docetaxel in Lung Cancer Clinical Trial page.

Latest updates to the Sitravatinib Combo vs Docetaxel in Lung Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedThe page's revision label changed from v3.5.2 to v3.5.3, signaling a newer build of the study record page.SummaryDifference0.0%

- Check25 days agoChange DetectedThe displayed revision/version label on the page footer was updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check53 days agoChange DetectedNapoli, Italy 80131 was replaced with Naples, Italy 80131 and the page revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check69 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check90 days agoChange DetectedThe update consists of revision metadata changes: Revision: v3.4.2 added and Revision: v3.4.1 removed, with no impact on study content, eligibility criteria, or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check97 days agoChange DetectedThe page's revision tag was updated to v3.4.1, and the previous revision tag v3.4.0 was removed.SummaryDifference0.0%

Stay in the know with updates to Sitravatinib Combo vs Docetaxel in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib Combo vs Docetaxel in Lung Cancer Clinical Trial page.